These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32497604)

  • 41. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and
    Tang L; Wang XJ; Baba H; Giganti F
    Eur Radiol; 2020 Jan; 30(1):247-260. PubMed ID: 31392480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
    Pahk K; Chung JH; Yi E; Kim S; Lee SH
    Eur J Radiol; 2018 Sep; 106():145-149. PubMed ID: 30150037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic ability of
    Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
    Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
    EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
    Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
    J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrating manual diagnosis into radiomics for reducing the false positive rate of
    Kang F; Mu W; Gong J; Wang S; Li G; Li G; Qin W; Tian J; Wang J
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2770-2779. PubMed ID: 31321483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics.
    van Timmeren JE; Carvalho S; Leijenaar RTH; Troost EGC; van Elmpt W; de Ruysscher D; Muratet JP; Denis F; Schimek-Jasch T; Nestle U; Jochems A; Woodruff HC; Oberije C; Lambin P
    PLoS One; 2019; 14(6):e0217536. PubMed ID: 31158263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [
    Thureau S; Modzelewski R; Bohn P; Hapdey S; Gouel P; Dubray B; Vera P
    Mol Imaging Biol; 2020 Jun; 22(3):764-771. PubMed ID: 31432388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
    Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J
    Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis.
    Chen J; Xia J; Huang J; Xu R
    BMC Cancer; 2020 Jun; 20(1):510. PubMed ID: 32493238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review on advances in
    Anan N; Zainon R; Tamal M
    Insights Imaging; 2022 Feb; 13(1):22. PubMed ID: 35124733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Information feedback of
    Mu Y; Gui J; Lang Z; Ren C; Yan L; Liu H; Liang J; Feng H
    J Infect Public Health; 2020 Sep; 13(9):1336-1341. PubMed ID: 31289004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of
    Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
    Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
    Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
    Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
    Divisi D; Barone M; Zaccagna G; Crisci R
    Ann Med; 2017 Nov; 49(7):626-635. PubMed ID: 28590774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiomics for the Prediction of Treatment Outcome and Survival in Patients With Colorectal Cancer: A Systematic Review.
    Staal FCR; van der Reijd DJ; Taghavi M; Lambregts DMJ; Beets-Tan RGH; Maas M
    Clin Colorectal Cancer; 2021 Mar; 20(1):52-71. PubMed ID: 33349519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
    Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
    J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.